Stifel Nicolaus Initiates Coverage on Hutchison China Meditech to Buy

Stifel Nicolaus Initiates Coverage on Hutchison China Meditech(NASDAQ:HCM). The shares have been rated Buy. The rating by Stifel Nicolaus was issued on Apr 11, 2016.

Leave a Reply

Hutchison China Meditech - Is it time to Sell?

Top Brokerage Firms are advising their investors on Hutchison China Meditech. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.